OtherArticle
METABOLISM, PHARMACOKINETICS, AND EXCRETION OF THE SUBSTANCE P RECEPTOR ANTAGONIST CP-122,721 IN HUMANS: STRUCTURAL CHARACTERIZATION OF THE NOVEL MAJOR CIRCULATING METABOLITE 5-TRIFLUOROMETHOXY SALICYLIC ACID (TFMSA) BY HPLC/MS/MS AND NMR SPECTROSCOPY
Kevin A Colizza, Mohamed Awad and Amin M Kamel
Drug Metabolism and Disposition March 14, 2007, DOI: https://doi.org/10.1124/dmd.106.014266